Menu

Blog

Page 1993

Nov 1, 2023

HbA1c: What’s Optimal, What’s My Data?

Posted by in categories: biotech/medical, genetics, life extension

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
Telomere and Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Continue reading “HbA1c: What’s Optimal, What’s My Data?” »

Nov 1, 2023

Study finds pleasurable music and ‘chills’ predict music-induced hypoalgesia

Posted by in categories: biotech/medical, media & arts, neuroscience

Music for pain relief and anxiety. I think somewhere else I read it helps heal brain injuries.


Further, subject-preferred music appears to induce a superior effect in relieving pain. This can be approached by allowing participants to select the most pleasant music from a prespecified list of songs or listen to their favorite music during the study. Nevertheless, the richness of emotions, meanings, and associations involved when listening to favorite music is poorly understood, especially regarding pain relief.

About the study

Continue reading “Study finds pleasurable music and ‘chills’ predict music-induced hypoalgesia” »

Nov 1, 2023

Alternative funeral options are changing how we honor our dead

Posted by in categories: chemistry, sustainability

When someone dies in the US, the vast majority of the time, their body is either embalmed, placed in a coffin, and buried in a cemetery, or cremated and the ashes returned to their loved ones in an urn — but those aren’t the only options.

A growing number of funeral directors, startups, and nonprofits are providing people with alternative ways to have their bodies honored after death — suggesting that the funeral landscape of tomorrow won’t be so binary.

Traditional burial and cremation has a cost for the environment, releasing chemicals into the ground or greenhouse gasses into the air, but a number of other funeral options are showing that death can be green.

Nov 1, 2023

Heart failure no longer death sentence for cancer survivors

Posted by in category: biotech/medical

Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer.

International experts and patients from the project gathered yesterday at the European Heart House, home of the European Society of Cardiology (ESC), as a unique think tank to improve the healthcare and quality of life for patients with cancer.

It is estimated that four million Europeans are diagnosed with cancer every year.2 Anthracycline chemotherapy has a prominent role in treating many forms of cancer-for example, up to 70% of patients with lymphoma receive an anthracycline regimen. Currently, there is no therapy to prevent anthracycline cardiotoxicity.

Nov 1, 2023

Brain implant lets man with locked-in syndrome share thoughts

Posted by in categories: computing, neuroscience

“To our knowledge, ours is the first study to achieve communication by someone who has no remaining voluntary movement.” — Jonas Zimmermann, a Wyss Center neuroscientist. Watch it here: https://www.freethink.com/health/locked-in-syndrome Freethink.


A man with total locked-in syndrome has used a brain-computer interface to spell out sentences with his mind.

Nov 1, 2023

New NK cell engaging immunotherapy approaches to target and potentially treat recalcitrant ovarian cancer

Posted by in categories: bioengineering, biotech/medical

The Wistar Institute’s David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against cancer.

In their publication titled, “Siglec-7 glyco-immune binding MAbs or NK cell engager biologics induce potent anti-tumor immunity against ,” published in Science Advances, the team demonstrates the preclinical feasibility of utilizing these new cancer immunotherapeutic approaches against diverse ovarian cancer types, including treatment-resistant and refractory ovarian cancers—alone or in combination with checkpoint inhibitor treatment.

The research started as a collaboration between Wistar’s Drs. Weiner and Mohamed Abdel-Mohsen, who were exploring the development of new glyco-signaling biologic tools that may be important in the fight against cancer.

Nov 1, 2023

Atlassian Customers Should Patch Latest Critical Vuln Immediately

Posted by in categories: computing, security

Atlassian has discovered yet another critical vulnerability in its Confluence Data Center and Server collaboration and project management platform, and it’s urging customers to patch the problem immediately. The latest advisory by Atlassian describes CVE-2023–22518 as an improper authorization vulnerability that affects all versions of the on-premises versions of Confluence.

It is the second critical vulnerability reported by Atlassian in a month, tied to its widely used Confluence Data Center and Server platform and among numerous security issues from the company during the past year. The previous bulletin (CVE-2023–22515) revealed a vulnerability that could allow an attacker to create unauthorized Confluence administrator accounts, thereby gaining access to instances. That vulnerability had a severity level of 10 and was discovered initially by some customers who reported they may have been breached by it.

To date, Atlassian is not aware of any active exploits of the newest vulnerability, which has a severity level of 9.1., though the company issued a statement encouraging customers to apply the patch. “We have discovered that Confluence Data Center and Server customers are vulnerable to significant data loss if exploited by an unauthenticated attacker,” Atlassian CISO Bala Sathiamurthy warned in a statement. “Customers must take immediate action to protect their instances.”

Nov 1, 2023

Lung cancer awareness: The importance of early detection and treatment

Posted by in categories: biotech/medical, chemistry

Lung cancer is the third most common cancer in the U.S. and there have been more than 235,000 new cases of lung cancer in 2021. While this figure is significant, the rate of new lung and bronchus cancer cases is decreasing, in part because more people have stopped smoking. This trend, along with innovations in early detection and treatment, is also reducing the number of lung cancer deaths.

Dr. Robert Taylor Ripley, associate professor of surgery in the Division of General Thoracic Surgery, is an expert in mesothelioma and thoracic surgical oncology. In the following Q&A, he discusses common causes of lung cancer, risks and the latest treatments.

Q: What are the most common causes of lung cancer? A: Smoking cigarettes is the most common cause, but others include secondhand smoke and environmental inhalants. We see a fair number of patients with lung cancer who have never smoked. Exposure to diesel exhaust or other chemicals may also cause lung cancer in some non-smokers.

Nov 1, 2023

It’s Cheap to Exploit Software — and That’s a Major Security Problem

Posted by in categories: cybercrime/malcode, mobile phones

How much would it cost to hack your phone? The best guess for an iPhone is between $0 and $65,000 — and that price mainly depends on you. If you skipped a really important security update, the cost is closer to $0.

Say you were up to date. That $65,000 figure is an upper cost of exploiting the median individual — switch to an Android, a Mac, or a PC and it could get a lot lower. Apple has invested enormous resources in hardening the iPhone. The asking price for an individual exploit, rather than as a service, can go as high as $8 million. Compare that to the cost of an exploit of a PDF reader like Adobe Acrobat — notoriously riddled with security vulnerabilities — which according to this TrendMicro research report (PDF) is $250 and up.

Switch from targeting a specific person to targeting any of the thousands of people at a large company and there are myriad ways in. An attacker only needs to find the cheapest one.

Nov 1, 2023

The Largest-Ever Simulation of The Universe Could Finally Reveal How We Got Here

Posted by in categories: computing, cosmology

How did we get here? Not just we humans, scrabbling about on a pale blue dot, hurtling around a star, hurtling around a supermassive black hole, hurtling through the local cluster. But how did the dot get here, and the star, and the black hole, and the cluster?

How did the incomprehensibly immense everything of it all get to where it is now, from an unimaginable nothing, billions of years ago?

That’s it, really, the question of questions. And, with the largest project of its kind to date, astronomers are attempting to find answers – by conducting computer simulations of the entire Universe.